Scott Minick, longtime executive and board member of leading pharmaceutical and biotechnology companies, has been elected as the new Chair of the Board of Directors for California Pacific Medical Center.
As Chair, Mr. Minick is responsible for ensuring that California Pacific Medical Center develops and implements policies to promote and improve the health of people from around the entire Bay Area and throughout the western United States. He has been a Director of California Pacific Medical Center?s Board since 2003 and has previously served as a member of CPMC?s Finance and Compliance Committees as well as serving on the advisory board of CPMC?s Child Development Center.
Of his appointment, Mr. Minick says, ?This is a world class hospital with world class physicians and staff, so I consider it both an honor and a privilege to be elected Chair of the Board of Directors at CPMC. Our Board looks forward to working with our physicians and leadership team to continue to build CPMC?s excellence in providing the finest health care in the San Francisco area.?
Mr. Minick is a Managing Director of ARCH Venture Partners, a premier provider of seed and early stage venture capital for technology firms. He joined ARCH as a Venture Partner in 1998. Prior to that, he was instrumental in the development and leadership of several life sciences companies, including SEQUUS Pharmaceuticals and OncoTherapeutics. Previously, Mr. Minick was an executive at Baxter and Eli Lilly.
His philanthropy and service to the community extends far beyond the Medical Center. In recent years, he has been involved in a number of not-for-profit Boards, including Northwestern University?s Kellogg School of Management as well as its new Biotechnology Program and as a Trustee of the Ross School.
Mr. Minick grew up in La Jolla, California. He received his B.A with honors from the University of California at San Diego, his M.B.A. from Northwestern University, and his postgraduate training in neurobiology at the Salk Institute.